We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mass Cytometry Profiles to Aid Drug Development

By LabMedica International staff writers
Posted on 15 May 2017
Print article
Image: Fluorescent imaging of a tumor section identifies different types of macrophages (green) and T-cells (blue) present in the microenvironment of renal cell carcinoma (Photo courtesy of Karina Silina, University of Zurich).
Image: Fluorescent imaging of a tumor section identifies different types of macrophages (green) and T-cells (blue) present in the microenvironment of renal cell carcinoma (Photo courtesy of Karina Silina, University of Zurich).
Cancer researchers used a novel mass cytometry technique to reveal potential biomarkers for detection of renal cell carcinoma and to identify targets for development of immunotherapeutic agents to treat this essentially incurable disease.

Renal cell carcinoma (ccRCC) is a common and lethal uro-genital cancer. Around 50% of ccRCC patients develop metastases despite treatment, and less than 10% of these patients survive five years. Targeted treatments such as tyrosine kinase inhibitors do not cure the disease, but novel checkpoint immunotherapies have shown considerable promise in some patients. Thus, new avenues to guide immunotherapy-based treatments are urgently needed.

Towards this end, investigators at the University of Zurich used mass cytometry with extensive antibody panels to perform in-depth immune profiling of samples from 73 ccRCC patients and five healthy controls. Mass cytometry enabled the quantification of more than 50 readouts at the single-cell level by combining metal isotope-labeled antibodies with mass spectrometry detection. With its ability to analyze millions of cells in a short time at low cost, mass cytometry represents the method of choice to assess the phenotypic diversity of T-cells and tumor-associated macrophages (TAMs) present in the tumor microenvironment in large patient cohorts.

The investigators reported in the May 4, 2017, issue of the journal Cell that by screening 3.5 million cells, they had identified 17 tumor-associated macrophage phenotypes and 22 T-cell phenotypes. This data expanded the view of T-cell immunosuppression phenotypes, suggested links between a TAM phenotype and populations of regulatory T-cells and CD8+ immunosuppressed T-cells, and identified an immune cell composition within the tumor microenvironment that was correlated with progression-free survival.

"The previous picture of immune defense was correct, but coarse," said first author, Dr. Stéphane Chevrier, a researcher in the institute of molecular life sciences at the University of Zurich. "With our methods to analyze individual immune cells, we have been able to create an immunological atlas of the tumor environment for the first time with high resolution and in a large patient cohort. As a result, many more facets have now come to light."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.